No Data
No Data
Serina Therapeutics Updates Equity Plan and Elects Directors
Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024
Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit
Serina Therapeutics Shares Rise After $10 Million in Financing
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate Into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients